Nicola Mary Aston

This inventor holds 14 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation, Glaxosmithkline LLC. Active years: 2006-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicola Mary Aston. Retrieved from https://idiyas.com/inventor/nicola-mary-aston

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14

% Patents Active = 21.4

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 106(Granted Patents)

Company Filing History:

Smithkline Beecham Corporation

Years Active: 2006-2013

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8575204 - Nicotinamide derivates useful as P38 inhibitors (2013-11-05),

2. 8252818 - Nicotinamide derivatives useful as P38 inhibitors (2012-08-28),

3. 7709506 - Nicotinamide derivatives useful as p38 inhibitors (2010-05-04),

4. 7626055 - Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors (2009-12-01),

5. 7572790 - Biphenyl carboxylic amide p38 kinase inhibitors (2009-08-11),

6. 7514456 - Nicotinamide derivatives useful as p38 inhibitors (2009-04-07),

7. 7432289 - 5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors (2008-10-07),

8. 7396843 - 5'-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors (2008-07-08),

9. 7309800 - Biphenylcarboxylic amide derivatives as p38 kinase inhibitors (2007-12-18),

10. 7271289 - Biphenylcarboxylic amide derivatives as p38 kinase inhibitors (2007-09-18),

11. 7208629 - 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors (2007-04-24),

12. 7183297 - Biphenyl-derivatives as p38-kinase inhibitors (2007-02-27),

13. 7151118 - Biphenylcarboxylic amide derivatives as p38-kinase inhibitors (2006-12-19),

14. 7125898 - Nicotinamide derivatives useful as p38 inhibitors. (2006-10-24),

Title: The Innovative Journey of Nicola Mary Aston

Introduction

Nicola Mary Aston is a noteworthy inventor based in Stevenage, GB, recognized for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio comprising 14 patents, Aston focuses her research on creating innovative compounds that hold the potential to address various medical conditions.

Latest Patents

Among her latest innovations are the patents for nicotinamide derivatives that are identified as useful P38 inhibitors. These compounds are meticulously designed to inhibit p38 kinase, playing a crucial role in the treatment of conditions or disease states that are mediated by p38 kinase activity and the cytokines produced by this activity. This advancement showcases Aston's dedication to enhancing therapeutic strategies in pharmacology.

Career Highlights

Nicola Mary Aston has had a profound impact throughout her career, working with leading pharmaceutical companies such as Glaxo Group Limited and SmithKline Beecham Corporation. Her experiences in these reputable organizations have equipped her with the knowledge and skills to pursue groundbreaking research and development in medicinal chemistry.

Collaborations

Collaboration has been an essential aspect of Aston's journey, working alongside talented professionals like Paul Bamborough and Ann Louise Walker. Together, they have contributed to a collaborative environment that fosters innovation and drives forward their research endeavors.

Conclusion

In conclusion, Nicola Mary Aston's body of work exemplifies the essence of ingenuity and collaboration in the field of invention. Her patents reflect her commitment to improving health outcomes through innovation, making her an influential figure in the world of pharmaceutical research.

Profile summary based on public USPTO records.